Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier
RSC Pharmaceutics · 2025 · 2 (6) · 1349-1375
DOI: 10.1039/d5pm00204d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Ruben J. Boado. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The brain microvasculature represents the blood–brain barrier (BBB) in vivo and it is permeable only to small lipophilic molecules.
Zitieren
APA
Boado, R. J. (2025). Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier. RSC Pharmaceutics, 2(6), 1349-1375. https://doi.org/10.1039/d5pm00204d
Vancouver
Boado RJ. Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier. RSC Pharmaceutics. 2025;2(6):1349-1375. doi:10.1039/d5pm00204d
BibTeX
@article{Boado2025,
author = {Boado, Ruben J.},
title = {Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood–brain barrier},
journal = {RSC Pharmaceutics},
year = {2025},
volume = {2},
number = {6},
pages = {1349--1375},
doi = {10.1039/d5pm00204d}
}
EUVIMED